Opioid settlements with companies like Purdue Pharma, Walmart, and Johnson & Johnson have led to headline-grabbing ...

The Maine Department of Environmental Protection has issued a Notice of Violation to Mallinckrodt, formerly known as the HoltraChem Manufacturing Company. For several decades, the company manufactured ...

Trust handling opioid claims loses on products exclusion No coverage under 30 of Mallinckrodt’s policies, court says American International Group Inc.'s successful bid to avoid covering litigation ...

The department charges that Mallinckrodt has done an insufficient job removing mercury from its former plant and has attempted to dodge its legal responsibilities. The Department of Environmental ...

— We have everything you need: full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; ...

— We have everything you need: full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; ...

Bengaluru: Mallinckrodt and Endo , drugmakers with a shared history of bankruptcy and U.S. opioid litigation, will merge in a deal valued at nearly $7 billion to boost scale for selling their ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

Malvern-based Endo has agreed to merge with Mallinckrodt in a cash and stock deal, valuing the combined pharmaceutical company at $6.7 billion, writes John George for the Philadelphia Business Journal ...

Endo and Mallinckrodt, two drugmakers seeking to recover from opioid lawsuits and bankruptcies, are betting a combination will help. Investors took a dim view Thursday. Shares of Endo fell more ...

We will always give you the option to opt out of our marketing. Wachtell Lipton Rosen & Katz and Davis Polk & Wardwell have scored lead roles on the $6.7bn merger of drugmakers Mallinckrodt and Endo.

Pharmaceutical companies Mallinckrodt Pharmaceuticals Plc and Endo Inc. have signed an agreement to create a combined company worth $6.7 billion. This is reported in a joint press release. Under the ...